External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

NCT05537662 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DEVICE: Standard of care neuromodulation therapy (SCS or DRG)

Sponsor

Abbott Medical Devices